Early Treatment of Favipiravir in COVID-19 Patients Without Pneumonia: a Multicentre, Open-Labelled, Randomized Control Study
EMERGING MICROBES & INFECTIONS(2022)
Key words
COVID-19,Favipiravir,Thailand,antiviral,RdRp inhibitor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined